儿童喘治疗的新方法
Riccardo Castagnoli1,2, Ilaria Brambilla1,2, Mattia Giovannini3,4
1Pediatric Unit, Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia.
Current opinion in allergy and clinical immunology
|June 26, 2023
概括
儿科喘管理的最新进展包括新的抗炎疗法和严重病例的生物疗法. 需要进一步的研究来指导最佳治疗选择,并确定针对个性化儿科喘护理的生物标志物.
科学领域:
- 儿科肺病学 儿科肺病学
- 过敏和免疫学 过敏和免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 儿童喘管理已经发展,更新的指导方针强调抗炎治疗.
- 症状性支气管扩张作为单一疗法不再推用于轻度喘.
- 生物疗法已经成为严重,不受控制的儿科喘的重大进展.
研究的目的:
- 审查儿童喘管理的最新进展.
- 突出治疗小儿喘的新型治疗方法,无论是轻症还是重症.
- 讨论在选择最佳疗法和生物标志物方面需要进一步证据的必要性.
主要方法:
- 对最近的研究和关于儿童喘管理的指南的文献综述.
- 对新型抗炎疗法和生物疗法的分析.
- 评估当前关于儿童严重和不受控制的喘的证据.
主要成果:
- 扩大了儿童喘的治疗选择,包括早期的抗炎药物使用.
- 目前的指导方针建议不要单独使用症状性支气管扩展剂进行治疗.
- 生物疗法已经改变了严重儿科喘的治疗环境.
结论:
- 临床医生需要更多的证据来指导治疗选择,特别是严重的儿科喘.
- 识别预测生物标志物对于选择适当的创新疗法至关重要.
- 个性化医疗方法在儿科喘护理中越来越重要.
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
357
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
357
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma: Pathogenesis and Management
458
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
458
Antiasthma Drugs: Leukotriene Modifiers
371
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
371
Asthma-I: Introduction
2.7K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.7K
Drugs Used in Lower Respiratory Disorders: Overview
504
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
504


